Your browser does not support javascript:   Search for gard hereSearch for news-and-events here.

Diseases

Genetic and Rare Diseases Information Center (GARD)

Print friendly version

Hemangioma thrombocytopenia syndrome


Other Names for this Disease

  • Kasabach Merritt phenomenon
  • Kasabach Merritt syndrome
  • KMP
  • Thrombocytopenia-hemangioma syndrome
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.

Overview

Hemangioma thrombocytopenia syndrome is characterized by profound thrombocytopenia in association with two rare vascular tumors: kaposiform hemangioendotheliomas and tufted angiomas. The profound thrombocytopenia can cause life threatening bleeding and progress to a disseminated coagulopathy in patients with these tumors.[1][2] The condition typically occurs in early infancy or childhood, although prenatal cases (diagnosed with the aid of ultrasonography), newborn presentations, and rare adult cases have been reported.[3]
Last updated: 10/19/2010

References

  1. Adams D. Kasabach-Merritt phenomenon. National Organization for Rare Disorders (NORD). 2008; http://www.rarediseases.org/search/rdbdetail_abstract.html?disname=Kasabach-Merritt%20phenomenon. Accessed 10/19/2010.
  2. Vazquez MP. Kasabach-Merritt syndrome. Orphanet. 2006; http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&Expert=2330. Accessed 10/19/2010.
  3. Krafchik BR, Hendricks LK, Faguet GB, Kuthiala S. Kasabach-Merritt Syndrome. eMedicine. 2010; http://emedicine.medscape.com/article/202455-overview. Accessed 10/19/2010.
Your Questions Answered
by the Genetic and Rare Diseases Information Center

Please contact us with your questions about Hemangioma thrombocytopenia syndrome. We will answer your question and update these pages with new resources and information.

Basic Information

  • DermNet NZ is an online resource about skin diseases developed by the New Zealand Dermatological Society Incorporated. DermNet NZ provides information about this condition.
  • The National Organization for Rare Disorders (NORD) is a federation of more than 130 nonprofit voluntary health organizations serving people with rare disorders. Click on the link to view information on this topic.

In Depth Information

  • Medscape Reference provides information on this topic. Click on the link to view this information. You may need to register to view the medical textbook, but registration is free.
  • Online Mendelian Inheritance in Man (OMIM) is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine. 
  • Orphanet is a European reference portal for information on rare diseases and orphan drugs.  Access to this database is free of charge.
  • PubMed is a searchable database of medical literature and lists journal articles that discuss Hemangioma thrombocytopenia syndrome. Click on the link to view a sample search on this topic.
Other Names for this Disease
  • Kasabach Merritt phenomenon
  • Kasabach Merritt syndrome
  • KMP
  • Thrombocytopenia-hemangioma syndrome
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.